C509-0907 Screening compound: 2-[(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide

C509-0907 Screening compound: 2-[(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide
C509-0907 Screening compound: 2-[(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C509-0907
2-[(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C509-0907

Molecular Formula

C29H34ClN3OS (C29 H34 ClN3 OS)

Compound Name

2-[(7-chloro-1,2,3,4-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide

IUPAC name

2-[(7-chloro-1234-tetrahydroacridin-9-yl)sulfanyl]-N-({1-[(3-methylphenyl)methyl]piperidin-4-yl}methyl)acetamide

SMILES

Cc1cccc(CN2CCC(CNC(CSc3c(cc(cc4)Cl)c4nc4c3CCCC4)=O)CC2)c1

InChI

InChI=1S/C29H34ClN3OS/c1-20-5-4-6-22(15-20)18-33-13-11-21(12-14-33)17-31-28(34)19-35-29-24-7-2-3-8-26(24)32-27-10-9-23(30)16-25(27)29/h4-6,9-10,15-16,21H,2-3,7-8,11-14,17-19H2,1H3,(H,31,34)

InChI Key

ZVVDBXPLICPQTN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14763122

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

508.13

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.495

Distribution Coefficient, logD

4.002

Water Solubility, LogSw

-6.17

Polar Surface Area

37.923

Acid Dissociation Constant (pKa)

14.77

Base Dissociation Constant (pKb)

9.89

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

44.80

C509-0907 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C509-0907 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C509-0907?
Check Price and Availability of C509-0907, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C509-0907 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C509-0907
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C509-0907
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C509-0907 available by request